ZA200200504B - Synthetic routes for the preparation of rhinovirus protease inhibitors and key intermediates. - Google Patents

Synthetic routes for the preparation of rhinovirus protease inhibitors and key intermediates. Download PDF

Info

Publication number
ZA200200504B
ZA200200504B ZA200200504A ZA200200504A ZA200200504B ZA 200200504 B ZA200200504 B ZA 200200504B ZA 200200504 A ZA200200504 A ZA 200200504A ZA 200200504 A ZA200200504 A ZA 200200504A ZA 200200504 B ZA200200504 B ZA 200200504B
Authority
ZA
South Africa
Prior art keywords
group
compound
formula
independently
cycloalkyl
Prior art date
Application number
ZA200200504A
Other languages
English (en)
Inventor
Qingping Tian
Naresh K Nayyar
Srinivasan Babu
Junhua Tao
Terence Jarold Moran
Raymond Dagnino Jr
Lennert J Mitchell
Travis Paul Remarchuk
Michael Joseph Melnick
Steven Lee Bender
Original Assignee
Agouron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agouron Pharma filed Critical Agouron Pharma
Publication of ZA200200504B publication Critical patent/ZA200200504B/en

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J19/24—Stationary reactors without moving elements inside
    • B01J19/2415—Tubular reactors
    • B01J19/2435—Loop-type reactors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J19/24—Stationary reactors without moving elements inside
    • B01J19/2475—Membrane reactors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/34—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/26—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of esters of sulfonic acids
    • C07C303/28—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of esters of sulfonic acids by reaction of hydroxy compounds with sulfonic acids or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/732—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids of unsaturated hydroxy carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00049—Controlling or regulating processes
    • B01J2219/00051—Controlling the temperature
    • B01J2219/00074—Controlling the temperature by indirect heating or cooling employing heat exchange fluids
    • B01J2219/00087—Controlling the temperature by indirect heating or cooling employing heat exchange fluids with heat exchange elements outside the reactor
    • B01J2219/00099—Controlling the temperature by indirect heating or cooling employing heat exchange fluids with heat exchange elements outside the reactor the reactor being immersed in the heat exchange medium
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00049—Controlling or regulating processes
    • B01J2219/00051—Controlling the temperature
    • B01J2219/00159—Controlling the temperature controlling multiple zones along the direction of flow, e.g. pre-heating and after-cooling

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pyrrole Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
ZA200200504A 1999-08-24 2002-01-21 Synthetic routes for the preparation of rhinovirus protease inhibitors and key intermediates. ZA200200504B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15035899P 1999-08-24 1999-08-24

Publications (1)

Publication Number Publication Date
ZA200200504B true ZA200200504B (en) 2003-03-26

Family

ID=22534156

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200200504A ZA200200504B (en) 1999-08-24 2002-01-21 Synthetic routes for the preparation of rhinovirus protease inhibitors and key intermediates.

Country Status (20)

Country Link
EP (1) EP1206450A1 (hu)
JP (1) JP2003507453A (hu)
KR (1) KR20020046283A (hu)
CN (1) CN1168713C (hu)
AR (1) AR025380A1 (hu)
AU (1) AU770221B2 (hu)
BR (1) BR0013306A (hu)
CA (1) CA2376452A1 (hu)
CO (1) CO5200782A1 (hu)
CZ (1) CZ2002632A3 (hu)
HK (1) HK1049336B (hu)
HU (1) HUP0203365A3 (hu)
IL (1) IL147674A0 (hu)
MX (1) MXPA02001944A (hu)
PE (1) PE20010517A1 (hu)
PL (1) PL353997A1 (hu)
TW (1) TWI245040B (hu)
UY (1) UY26307A1 (hu)
WO (1) WO2001014329A1 (hu)
ZA (1) ZA200200504B (hu)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT4846B (lt) 1998-04-30 2001-10-25 Agouron Pharmaceuticals,Inc. Junginiai prieš pikornavirusą, jų gavimas ir panaudojimas
JP2003506457A (ja) 1999-08-04 2003-02-18 アグロン・ファーマシュウティカルズ・インコーポレーテッド 抗ピコルナウィルス化合物及び組成物、その医薬的使用、並びにその合成のための物質
PA8507801A1 (es) 1999-12-03 2002-08-26 Agouron Pharma Compuestos y composiciones antipicornavirales, sus usos farmaceuticos y los materiales para su sintesis
PA8515201A1 (es) 2000-04-14 2002-10-24 Agouron Pharma Compuestos y composiciones antipicornavirales; sus usos farmaceuticos y los materiales para su sintesis
EP1355878A2 (en) 2000-06-14 2003-10-29 Agouron Pharmaceuticals, Inc. Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
CN1309712C (zh) * 2004-04-02 2007-04-11 中国科学院上海有机化学研究所 Ag7088类化合物的关键中间体的前体及其合成方法
US20230157998A1 (en) 2020-03-06 2023-05-25 Pfizer Inc. Methods of Inhibiting SARS-CoV-2 Replication and Treating Corona Virus Disease 2019
CN115260074B (zh) * 2022-08-02 2024-06-21 爱斯特（成都）生物制药股份有限公司 一种口服抗病毒药物Paxlovid中间体的制备方法
CN115322130B (zh) * 2022-08-02 2024-05-14 南京正济医药研究有限公司 制备(s)-2-(boc-氨基)-3-[(s)-2-氧代-3-吡咯烷基]丙酸甲酯

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0910572B1 (en) * 1996-05-14 2005-04-27 Agouron Pharmaceuticals, Inc. Inhibitors of picornavirus 3c proteases and methods for their use and preparation
ES2206907T3 (es) * 1997-03-28 2004-05-16 Agouron Pharmaceuticals, Inc. Compuestos anti-picornavirus, composiciones que contienen estos compuestos y sus procedimientos de utilizacion.
US5962487A (en) * 1997-12-16 1999-10-05 Agouron Pharmaceuticals, Inc. Antipicornaviral compounds and methods for their use and preparation
LT4846B (lt) * 1998-04-30 2001-10-25 Agouron Pharmaceuticals,Inc. Junginiai prieš pikornavirusą, jų gavimas ir panaudojimas

Also Published As

Publication number Publication date
AR025380A1 (es) 2002-11-20
CO5200782A1 (es) 2002-09-27
JP2003507453A (ja) 2003-02-25
PE20010517A1 (es) 2001-05-16
AU6797100A (en) 2001-03-19
CZ2002632A3 (cs) 2003-04-16
KR20020046283A (ko) 2002-06-20
EP1206450A1 (en) 2002-05-22
HUP0203365A2 (hu) 2003-02-28
CA2376452A1 (en) 2001-03-01
CN1168713C (zh) 2004-09-29
MXPA02001944A (es) 2002-10-31
PL353997A1 (en) 2003-12-15
BR0013306A (pt) 2002-05-28
WO2001014329A1 (en) 2001-03-01
UY26307A1 (es) 2001-04-30
HK1049336B (zh) 2005-05-20
CN1374947A (zh) 2002-10-16
HK1049336A1 (en) 2003-05-09
AU770221B2 (en) 2004-02-19
IL147674A0 (en) 2002-08-14
TWI245040B (en) 2005-12-11
HUP0203365A3 (en) 2003-12-29

Similar Documents

Publication Publication Date Title
EP2477967B1 (en) Process for preparing 3-[(4S)-8-bromo-1-methyl-6-(2-pyridinyl)-4 H-imidazo[1,2-a][1,4]benzodiazepine-4-yl] propionic acid methyl ester or the benzene sulfonate salt thereof, and compounds useful in that process
JP4921646B2 (ja) １−（３−ベンジルオキシプロピル）−５−（２−置換プロピル）インドリン誘導体およびその使用方法
ZA200200504B (en) Synthetic routes for the preparation of rhinovirus protease inhibitors and key intermediates.
CN114605310B (zh) 一种氮杂五元环并三元环羧酸酯衍生物及其盐的合成方法
EP3507282B1 (en) Process for preparing indole carboxamide compounds
AU2643399A (en) Process for preparing a protected 4-aminomethyl-pyrrolidin- 3-one
Szcześniak et al. Solid supported Hayashi–Jørgensen catalyst as an efficient and recyclable organocatalyst for asymmetric Michael addition reactions
US6774243B2 (en) Efficient synthetic routes for the preparation of rhinovirus protease inhibitors and key intermediates
US6355807B1 (en) Efficient synthetic routes for the preparation of rhinovirus protease inhibitors and key intermediates
Werner et al. Fluorous parallel synthesis of a piperazinedione-fused tricyclic compound library
JP4294121B2 (ja) ピリドンカルボン酸誘導体の製造方法およびその中間体
MXPA02001947A (es) Proceso y compuestos intermedios para la preparacion de isoxazolcooxamidas y analogos.
JPWO2002048153A1 (ja) Ｇｍ−９５物質の製法
Matsuyama et al. Conjugate addition of 6-membered hydrazine to chiral tert-butyl (E)-2-(p-tolylsulfinyl) cinnamates. Synthesis of (S)-celacinnine
Anslow et al. Development of an alanine-derived chiral stabilized azomethine ylid based on the 5-(2′-naphthyl) morpholin-2-one template
JP2020529398A (ja) モノバクタム系抗生物質およびその中間体を製造するための化学的方法
CN117466796A (zh) 一种((2R,7aS)-2-氟六氢-1H-吡咯嗪-7a-基)甲醇的制备方法
WO2007035003A1 (ja) 光学活性なピペラジン化合物の製造方法
CN115703819A (zh) 大环类化合物及其中间体的制备方法
WO2023039068A1 (en) Compositions and methods for synthesis of peptide nucleic acid intermediates
CN118307470A (zh) 一种6,7-二氢-5H-环戊并[b]吡啶-4-胺的合成方法
CN115611894A (zh) 一种含氮螺环化合物或其药学上可接受的盐及其制备方法和应用
WO2004046173A1 (en) Scaffolds useful to the synthesis of compounds with biological activity
CA2500558A1 (en) A process for the preparation of aza-containing bicyclic compounds and the use thereof in the preparation of cilazapril
SK19242001A3 (sk) Spôsob prípravy substituovaných [1,4]diazepino[6,7,1-hi]indol-4-ónov